Role of Cardiovascular Magnetic Resonance in Cardiac Amyloidosis: A Narrative Review-Reference-Cited by-同舟云学术

Role of Cardiovascular Magnetic Resonance in Cardiac Amyloidosis: A Narrative Review

Published:2024-04-11 Issue:4 Volume:14 Page:407
ISSN:2075-4426
Container-title:Journal of Personalized Medicine
language:en
Short-container-title:JPM

Author:

Maggialetti Nicola¹^ORCID,Torrente Andrea¹,Lorusso Giovanni¹,Villanova Ilaria¹,Ficco Michele²,Gravina Matteo³,Ferrari Cristina⁴^ORCID,Giordano Luca⁵,Granata Vincenza⁶^ORCID,Rubini Dino⁷^ORCID,Lucarelli Nicola Maria¹^ORCID,Stabile Ianora Amato Antonio¹,Scardapane Arnaldo⁸^ORCID

Affiliation:

1. Section of Radiology and Radiation Oncology, Interdisciplinary Department of Medicine, University of Bari “Aldo Moro”, 70124 Bari, Italy

2. U.O.C. Radiologia, P.O. San Paolo, ASL Bari, 70123 Bari, Italy

3. Radiology Unit, Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, Italy

4. Section of Nuclear Medicine, Interdisciplinary Department of Medicine, University of Bari “Aldo Moro”, Piazza Giulio Cesare 11, 70124 Bari, Italy

5. U.O.C. Radiodiagnostica, Ospedaliera Vito Fazzi, 73100 Lecce, Italy

6. Division of Radiology, Istituto Nazionale Tumori IRCCS Fondazione Pascale-IRCCS di Napoli, 80131 Naples, Italy

7. Department of Precision Medicine, University of Campania “L. Vanvitelli”, 80138 Naples, Italy

8. Sperimental Medicine Department, University of Salento, 73100 Lecce, Italy

Abstract

Amyloidosis is a rare infiltrative condition resulting from the extracellular accumulation of amyloid fibrils at the cardiac level. It can be an acquired condition or due to genetic mutations. With the progression of imaging technologies, a non-invasive diagnosis was proposed. In this study, we discuss the role of CMR in cardiac amyloidosis, focusing on the two most common subtypes (AL and ATTR), waiting for evidence-based guidelines to be published.

Publisher

MDPI AG

Link

https://www.mdpi.com/2075-4426/14/4/407/pdf

Reference44 articles.

1. Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta-analysis of screening studies;Aimo;Eur. J. Heart Fail.,2022

2. Cardiac amyloidosis;Hawkins;Clin. Med.,2018

3. Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on myocardial and Pericardial Diseases;Rapezzi;Eur. J. Heart Fail.,2021

4. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging;Dorbala;J. Nucl. Cardiol.,2019

5. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure;McDonagh;Eur. Heart J.,2021

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in the Diagnosis and Management of Cardiac Amyloidosis: A Literature Review;Cardiology Research;2024-08